We carried out an announced comprehensive inspection at ScreenCancer UK Head Office on 17 July 2019. The inspection was the services first inspection since registering with CQC in October 2018. We carried out this inspection under Section 60 of the Health and Social Care Act 2008 as part of our regulatory functions. This inspection was planned to check whether the service was meeting the legal requirements and regulations associated with the Health and Social Care Act 2008.
ScreenCancer UK Head Office provide skin screening services undertaken by a pharmacist in a number of Boots the Chemist stores across the UK. Skin scanning images are sent to ScreenCancer UK Head Office, where they are reviewed by specialists/dermatologists for a diagnosis, specialist advice and if required, treatment recommendations. Patients under the age of 18 are not provided with screening without the appropriate supervision of a parent and/or legal guardian.
This service is registered with CQC under the Health and Social Care Act 2008 in respect of some, but not all, of the services it provides. There are some exemptions from regulation by CQC which relate to particular types of service and these are set out in Schedule 2 of The Health and Social Care Act 2008 (Regulated Activities) Regulations 2014. ScreenCancer UK Head Office provides a range of non-surgical screening. For example, mole screening which is not within the registration of this service, instead they are registered with the contracted organisation and are regulated under their own individual registration. Therefore, we did not inspect or report on these services. The operational manager is the registered manager.
A registered manager is a person who is registered with the Care Quality Commission to manage the service. Like registered providers, they are ‘registered persons’. Registered persons have legal responsibility for meeting the requirements in the Health and Social Care Act 2008 and associated Regulations about how the service is run.
We were unable to speak to any patients during the inspection. We reviewed online reviews, from which we saw that there were five responses in the last 12 months, all of which were positive.
Our key findings were:
- The provider had systems, processes and practices to keep people safe.
- Systems to support safety within the head office and outsourced buildings (Boots the Chemist) were effective and well embedded.
- The provider put the Patients’ needs before financial consideration.
- There was a strong emphasis on continuous learning for clinical staff.
- There was information for patients on how to approach their treatment. This included providing links to the latest dermatological research.
- Patients were enabled to be as knowledgeable about their choices as possible.
Dr Rosie Benneyworth BM BS BMedSci MRCGP
Chief Inspector of Primary Medical Services and Integrated Care